Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes

Published:2020-12 Issue: Volume:115 Page:102543
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Lombardi Angela,Concepcion Erlinda,Hou Hanxi,Arib Hanane,Mezei Mihaly,Osman Roman,Tomer Yaron

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Juvenile Diabetes Research Foundation United States of America

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference71 articles.

1. Type 1 diabetes-early life origins and changing epidemiology;Norris;Lancet Diabetes Endocrinol,2020

2. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes;Herold;Nat. Rev. Immunol.,2013

3. Epidemiology of type 1 diabetes;Maahs;Endocrinol Metab. Clin. N. Am.,2010

4. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009;Dabelea;Jama,2014

5. Type 1 diabetes;Barnett;Lancet,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the Potential of Retro-Inverso (RI) Peptides as Future Drug Candidates;International Journal of Peptide Research and Therapeutics;2024-09-10

2. Structural and biochemical analysis of highly similar HLA-B allotypes differentially associated with type 1 diabetes;Journal of Biological Chemistry;2024-08

3. Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy;Frontiers in Immunology;2024-06-12

4. Current trends and future directions for the synthesis and pharmacological applications of 2-(2-cyanopyrrolidin-1-yl)-N-3-hydroxyadamantan-1-yl) acetamide (Gliptins);Medicinal Chemistry Research;2024-06-11

5. The importance of stereochemistry in the disorder-order continuum of protein-protein interactions;2024-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3